Loading...
Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cells.
Stovold, Rachel Blackhall, Fiona H Meredith, S Hou, Jian-Mei Dive, Caroline White, A
Stovold, Rachel
Blackhall, Fiona H
Meredith, S
Hou, Jian-Mei
Dive, Caroline
White, A
Citations
Altmetric:
Abstract
Small cell lung cancer (SCLC) is characterised by an aggressive clinical course with invariable resistance to chemotherapy despite initially high response rates. There has been little improvement in outcome over the past few decades, with no breakthrough yet in targeted therapies. Recent preclinical data and studies of circulating tumour cells (CTCs) highlight distinct cellular heterogeneity within SCLC. Better understanding of how these phenotypes contribute to metastasis and tumour progression might pave the way for development of more successful targeted therapies. Here we review these studies, their implications for future research and for the incorporation of biomarkers reflecting neuroendocrine, epithelial and mesenchymal phenotypes in clinical studies.
Description
Date
2011-12-15
Publisher
Keywords
Type
Article
Citation
Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cells. 2011: Lung Cancer